AlphaFold predicted structure
TOP2B · Q02880

Mean pLDDT
73.4/ 100
Confident
1,626 residues
Confidence breakdown
- Very high(≥ 90)44%
- Confident(70–90)26%
- Low(50–70)3%
- Very low(< 50)28%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
DNA topoisomerase II beta
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary immunodeficiency or monogenic inflammatory bowel disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMonogenic hearing loss
MONOALLELIC, autosomal or pseudoautosomal, paternally imprinted (maternal allele expressed)Fetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedB-cell immunodeficiency, distal limb anomalies, and urogenital malformations
neoplasm
small cell lung carcinoma
breast cancer
small cell carcinoma
cardiomyopathy
acute myeloid leukemia
neuroblastoma
acute lymphoblastic leukemia
neurodegenerative disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
DNA topoisomerase 2-beta
Key decatenating enzyme that alters DNA topology by binding to two double-stranded DNA molecules, generating a double-stranded break in one of the strands, passing the intact strand through the broken strand, and religating the broken strand. Plays a role in B-cell differentiation
Curated MONDO disease pages that list TOP2B among their top associated genes.
TOP2B · Q02880

Mean pLDDT
73.4/ 100
Confident
1,626 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0